Using genomics to define the antigenic targets of checkpoint blockade cancer immunotherapy

被引：0
|
作者：
Schreiber, Robert D.
机构：
来源：
CANCER IMMUNOLOGY RESEARCH | 2015年 / 3卷 / 10期
关键词：
D O I：
10.1158/2326-6074.TUMIMM14-IA08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA08
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Cancer immunotherapy using checkpoint blockade
    Ribas, Antoni
    Wolchok, Jedd D.
    SCIENCE, 2018, 359 (6382) : 1350 - +
  • [2] Checkpoint blockade in cancer immunotherapy
    Korman, AJ
    Peggs, KS
    Allison, JP
    ADVANCES IN IMMUNOLOGY, VOL 90: CANCER IMMUNOTHERAPY, 2006, 90 : 297 - 339
  • [3] Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
    Matthew M. Gubin
    Xiuli Zhang
    Heiko Schuster
    Etienne Caron
    Jeffrey P. Ward
    Takuro Noguchi
    Yulia Ivanova
    Jasreet Hundal
    Cora D. Arthur
    Willem-Jan Krebber
    Gwenn E. Mulder
    Mireille Toebes
    Matthew D. Vesely
    Samuel S. K. Lam
    Alan J. Korman
    James P. Allison
    Gordon J. Freeman
    Arlene H. Sharpe
    Erika L. Pearce
    Ton N. Schumacher
    Ruedi Aebersold
    Hans-Georg Rammensee
    Cornelis J. M. Melief
    Elaine R. Mardis
    William E. Gillanders
    Maxim N. Artyomov
    Robert D. Schreiber
    Nature, 2014, 515 : 577 - 581
  • [4] Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
    Gubin, Matthew M.
    Zhang, Xiuli
    Schuster, Heiko
    Caron, Etienne
    Ward, Jeffrey P.
    Noguchi, Takuro
    Ivanova, Yulia
    Hundal, Jasreet
    Arthur, Cora D.
    Krebber, Willem-Jan
    Mulder, Gwenn E.
    Toebes, Mireille
    Vesely, Matthew D.
    Lam, Samuel S. K.
    Korman, Alan J.
    Allison, James P.
    Freeman, Gordon J.
    Sharpe, Arlene H.
    Pearce, Erika L.
    Schumacher, Ton N.
    Aebersold, Ruedi
    Rammensee, Hans-Georg
    Melief, Cornelis J. M.
    Mardis, Elaine R.
    Gillanders, William E.
    Artyomov, Maxim N.
    Schreiber, Robert D.
    NATURE, 2014, 515 (7528) : 577 - +
  • [5] Cancer Immunotherapy: Beyond Checkpoint Blockade
    Dougan, Michael
    Dranoff, Glenn
    Dougan, Stephanie K.
    ANNUAL REVIEW OF CANCER BIOLOGY, VOL 3, 2019, 3 : 55 - 75
  • [6] Neoadjuvant checkpoint blockade for cancer immunotherapy
    Topalian, Suzanne L.
    Taube, Janis M.
    Pardoll, Drew M.
    SCIENCE, 2020, 367 (6477) : 525 - +
  • [7] Checkpoint Blockade Immunotherapy for Cancer Comes of Age
    Brower, Vicki
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (03):
  • [8] Understanding the checkpoint blockade in lung cancer immunotherapy
    Dal Bello, Maria Giovanna
    Alama, Angela
    Coco, Simona
    Vanni, Irene
    Grossi, Francesco
    DRUG DISCOVERY TODAY, 2017, 22 (08) : 1266 - 1273
  • [9] A new checkpoint receptor targets for cancer immunotherapy
    Li, Yangyang
    Tian, Zhigang
    Sun, Rui
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [10] Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies
    Byun, David J.
    Wolchok, Jedd D.
    Rosenberg, Lynne M.
    Girotra, Monica
    NATURE REVIEWS ENDOCRINOLOGY, 2017, 13 (04) : 195 - 207
12345